Stay updated on Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial

Sign up to get notified when there's something new on the Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page shows a revision label update from v3.4.1 to v3.4.2, which does not modify study details or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T01:42:00.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision from v3.4.0 to v3.4.1 appears to be a minor site version update with no changes to study data, eligibility criteria, or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T23:30:13.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    UI and metadata updates include a new Show glossary control and updated labels: 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data' capitalization, and a revision note 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T19:42:03.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    - The page revision was updated from v3.3.3 to v3.3.4. No substantive changes to study details or related information.
    Difference
    0.0%
    Check dated 2026-01-14T03:41:09.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The Study Locations section was expanded to include multiple U.S. states (Arizona, Arkansas, California, Connecticut, Florida, Indiana, Kansas, Nebraska, Nevada, New Hampshire, New Jersey, New York, Pennsylvania, South Carolina, South Dakota, Tennessee, Texas, Utah, Wisconsin) and a new revision tag (v3.3.3).
    Difference
    2%
    Check dated 2025-12-23T21:21:58.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Revision tag updated to v3.3.2, replacing the previous v3.2.0.
    Difference
    0.0%
    Check dated 2025-11-25T11:12:54.000Z thumbnail image

Stay in the know with updates to Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial page.